European and Developing Countries Clinical Trials Partnership (EDCTP2): Calls for Proposals

EDCTP2 Calls for Proposals

Course(s) Offered: Medicine
Course Level: Graduate research
Provider: EDCTP
Country to Study in: Africa, Europe

Scholarship Description
The second programme of the European and Developing Countries Clinical Trials Partnership (EDCTP2) was launched in 2014 and will be implemented over a 10 year period.

The overall objective of EDCTP2 is to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for poverty-related diseases, in partnership with sub-Saharan Africa.

Proposals to EDCTP for funding must be submitted in response to published calls for proposals. EDCTP does not consider unsolicited and spontaneous proposals for funding that are not directly related to a published call for proposals. Information on this page is only a guidance for applicants to EDCTP2 Calls for Proposals to supplement the information provided in the Call text and Call documents.

Three distinct types of actions are supported under EDCTP2:
  • Research & Innovation Actions (RIAs).
  • Coordination & Support Actions (CSAs).
  • Training and Mobility Awards/Fellowships (TMAs).
Each call contains the key information that is needed in order to prepare a proposal, including the eligibility and evaluation criteria. The call for proposals also includes contact details in case of enquiries about the call.

Natural persons and legal entities that are public or private, for-profit or not-for-profit (e.g. universities, government departments, research organisations, non-governmental organisations, large companies and small to medium enterprises) regardless of their place of establishment or residence can participate in EDCTP2. They must demonstrate that they possess the operational and financial capacity to carry out the proposed tasks. While legal entities from anywhere in the world can participate in EDCTP2 projects, only legal entities established in the below-listed countries and territories may become ‘beneficiaries’ and automatically eligible to receive funding.

Eligible groups
Member countries of the EDCTP Association, including their overseas departments:
  • Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden and the United Kingdom (“European Participating States” in the EDCTP2 programme)
  • Burkina Faso, Cameroon, Congo, The Gambia, Ghana, Mali, Mozambique, Niger, Senegal, South Africa, Tanzania, Uganda, Zambia (“African Participating States” in the EDCTP2 programme).
Other countries of sub-Saharan Africa:
  • Angola, Benin, Botswana, Burundi, Cape Verde, Central African Republic, Chad, Comoros, Congo (Democratic Republic of), Djibouti,, Eritrea, Ethiopia, Gabon, Guinea, Guinea-Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mauritania, Mauritius, Namibia, Nigeria, Rwanda, São Tomé and Príncipe, Seychelles, Sierra Leone, Somalia, South Sudan, Sudan, Swaziland, Togo, Zimbabwe.
Other Member States of the European Union, which are not member countries of the EDCTP Association, including their overseas departments:
  • Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia, Slovenia.
Overseas Countries and Territories (OCT) linked to EU Member States: 
  • Anguilla, Aruba, Bermuda, Bonaire, British Virgin Islands, Cayman Islands, Curaçao, Falkland Islands, French Polynesia, Greenland, Montserrat, New Caledonia, Pitcairn Islands, Saba, Saint Barthélémy, Saint Helena, Saint Pierre and Miquelon, Sint Eustatius, Sint Maarten, Turks and Caicos Islands, Wallis and Futuna.
Countries Associated in full to Horizon 2020

Fields of study
In the EDCTP2 programme, "poverty-related diseases (PRDs)" include HIV, malaria, tuberculosis and the following neglected infectious diseases (NIDs): dengue/severe dengue; rabies; human African trypanosomiasis (sleeping sickness); leishmaniases; cysticercosis/taeniasis; dracunculiasis (guinea-worm disease); echinococcosis; foodborne trematodiases; lymphatic filariasis; mycetoma; onchocerciasis (river blindness); schistosomiasis; soil-transmitted helminthiases; Buruli ulcer; leprosy (Hansen disease); trachoma; yaws; diarrhoeal infections; lower respiratory infections; as well as emerging infectious diseases of particular relevance for Africa, such as Ebola or yellow fever.

Scholarship benefits
The funding rate and level for calls is indicated in the text of the individual call. The funding rate will be 100% of direct costs as well as 25% overhead to cover indirect costs. It is important to note the maximum EDCTP contribution that can be requested per action.

The EDCTP2 programme supports:
  • Clinical trials and related research activities on PRDs.
  • Capacity development for clinical trials and related research in sub-Saharan Africa.
Moreover, EDCTP2 promotes networking, coordination, alignment, collaboration and integration of national research programmes and activities on PRDs at scientific, management and financial levels.

Method of Application
All proposals must be submitted online using EDCTP’s electronic submission system EDCTPgrants which you can access via the EDCTP website. Only registered users of EDCTPgrants can apply for funding and submit proposals. EDCTP does not accept paper proposals or proposals sent via email attachment in response to calls for proposals. If you intend to participate in an EDCTP proposal, it is advisable to register with EDCTPgrants as soon as possible and well in advance of the call deadline. New users should click the Register button and follow the on-screen instructions to complete the registration process.

It is important to read the FAQ on EDCTP2 Calls and also visit the official webpage (link to it is below) for complete information on how to apply

Please refer to the ‘Our Calls/Calls‘ page of the EDCTP website for the information on specific deadlines (link is below)

The European and Developing Countries Clinical Trials Partnership or EDCTP is a partnership between the European Union (EU), Norway, Switzerland and developing countries and other donors, as well as the pharmaceutical industry, to enable clinical trials and the development of new medicines and vaccines against HIV/AIDS, tuberculosis, and malaria. The first EDCTP programme ended in May 2015. This second programme, called EDCTP2 programme, is planned for 2014 to 2024.

Application Deadline: Varies/ongoing
Open to International Applicants: Yes

More Scholarship Information and Application

Related: Research Scholarships for International Scholars

1 comment: